Lifeline Business Profile
Multiple Sclerosis
Multiple sclerosis: Stem cell transplantation may halt disease progression
New research provides further evidence of autologous hematopoietic stem cell transplantation as an effective treatment for multip ...
Stem Cell Transplants To Improve Multiple Sclerosis Outcomes
New clinical trial results provide evidence that high-dose immunosuppressive therapy followed by tra ...
High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS): A 3-Year Interim Report
ABSTRACT
Read more
Stem Cell MS Patients Lead Normal Life Thanks to aHSCT Procedure
People with MS who were involved in a long-term clinical trial are out and about enjo ...
New MS treatment using stem cells may produce revolutionary results
A novel Canadian treatment to halt the progression of multiple sclerosis (MS) is being hailed as revolutionary, after doctors and ...
The Lancet: New stem cell transplantation method may halt multiple sclerosis symptoms long-term, but therapy comes with high risk
A new use of chemotherapy followed by autologous haematopoietic stem cell transplantation (aHSCT) ha ...
Cancer treatment for MS patients gives "remarkable" results
BBC team follows MS patient Steven Storey's progress after the new treatment.
UK doctors in S ...
First Successful Therapy for Multiple Sclerosis: Stem Cells Lead the Way
Review of “Association of Non-myeloablative Hematopoietic Stem Cell Transplantation with N ...
"Miracle" stem cell therapy reverses multiple sclerosis
The treatment, is the first to reverse the symptoms of MS, which has no cure, and affects ar ...
MS Stem Cell Therapy Shows Promise
Autologous stem cell transplant after immunosuppressive therapy induced 3 year rem ...
Stem cell transplant may help patients with MS
An experimental treatment that uses a patient's own stem cells may offer new hope for people with mu ...
- Report on Remission in Patients with MS 3 Years After Stem Cell Transplant
- Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis.
- Ομφάλιος λώρος ενάντια στη σκλήρυνση κατά πλάκας
- Mesenchymal Stem Cells Drive New MS Study/Treatment
- Wilts man in stem cell trial
- Alternative Therapies for Multiple Sclerosis
- Jim's Umbilical Cord Stem Cell hUCSC Treatments
- Stem Cell Therapy Helps MS Woman
The facility of CBB Lifeline Biotech is Accredited by AABB International Standards for Cellular Therapy Products for Cord Blood Banking Services
Since October 2020 the clinical testing is performed by a third party accredited collaborator
LifeCord Patented Methodology
US Patent Office
